Lonza confident Moderna’s COVID-19 prospect will be ready for commercial production this year
Swiss company Lonza said it is confident that the new U.S. and Swiss plants it’s building to help make Moderna’s COVID-19 vaccine prospect will be ready for commercial production this year.